About me
Sam Kay is Vice President of Pharma at Basil Systems, where he leads AI-powered regulatory intelligence solutions for global pharmaceutical companies. A recognized authority in the field, Sam co-authored Chapter 6 of Regulatory Intelligence Reimagined (RAPS) and teaches Regulatory Intelligence & Strategy at Mount Marty University. His career spans leadership roles at Clarivate, Gilead Sciences, and PwC, with deep expertise in US drug labeling, FDA compliance, and AI applications in pharma. A frequent speaker and published contributor at major industry conferences, Sam's insights on FDA policy have also been featured by the Associated Press.
